Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04927832
Status:
UNKNOWN
Last Update Posted:
2022-07-27
First Post:
2021-06-09
Brief Title:
Detection of Small Fiber Neuropathies by the Non-invasive SUDOSCAN Method During Chronic Autoimmune Pathologies and or Unexplained Pain Syndromes
Sponsor:
Hôpital Européen Marseille
Organization:
Hôpital Européen Marseille
Study Overview
Official Title:
Detection of Small Fiber Neuropathies by the Non-invasive SUDOSCAN Method During Chronic Autoimmune Pathologies and or Unexplained Pain Syndromes
Status:
UNKNOWN
Status Verified Date:
2022-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SUDOCU
Brief Summary:
Very few studies have evaluated the prevalence of small fiber neuropathy SFN during pathologies that may be responsible for small fibers damage
SUDOSCAN is a new rapid 2 minutes automated reproducible and non-invasive technology to assess small fiber neuropathy by sweat function
With quantitative and reproducible results SUDOSCAN allows physicians to early detect and follow-up peripheral neuropathy to monitor disease progression and assess treatment efficacy for a better patient management
SUDOSCAN could allow the identification of SFN in painful patients apart from another pathology already diagnosed responsible for SFN
The purpose of the study SUDOCU is to assess the prevalence of small fiber neuropathies SFN in patients with systemic autoimmune pathologies or unexplained pain syndrome
SUDOSCAN is a new rapid 2 minutes automated reproducible and non-invasive technology to assess small fiber neuropathy by sweat function
With quantitative and reproducible results SUDOSCAN allows physicians to early detect and follow-up peripheral neuropathy to monitor disease progression and assess treatment efficacy for a better patient management
SUDOSCAN could allow the identification of SFN in painful patients apart from another pathology already diagnosed responsible for SFN
The purpose of the study SUDOCU is to assess the prevalence of small fiber neuropathies SFN in patients with systemic autoimmune pathologies or unexplained pain syndrome
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None